Get notified when SBEV files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (unchanged) — Going concern language remains unchanged between filings.
  • Material Weakness (worsened) — The material weakness disclosure now references the June 30, 2026 Form 10-Q instead of the March 31, 2026 Form 10-Q, indicating the weakness persisted into the more recent quarter.
NYSE: SBEV Endovia Health Sciences, Inc. S-1/A

Endovia Health Sciences rebrands amid going concern and material weakness

Filed August 20, 2026 · Compared to S-1 Aug 7, 2026 · ~1 min read

Key Changes

  • high

    Corporate name change to Endovia Health Sciences, Inc. effective August 24, 2026, reflecting a strategic shift to a cannabinoid health sciences platform.

    Prospectus Summary verify on EDGAR →
  • high

    Material weakness in internal controls persists, now disclosed as of June 30, 2026, due to limited segregation of duties and insufficient accounting staff.

    Risk Factors verify on EDGAR →
  • high

    Going concern language remains unchanged, indicating substantial doubt about the company's ability to continue as a going concern.

    Risk Factors verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.

Partner

Trade SBEV commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify